Clara Martínez-Vila

1.6k total citations
19 papers, 242 citations indexed

About

Clara Martínez-Vila is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Clara Martínez-Vila has authored 19 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Clara Martínez-Vila's work include Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (5 papers) and Melanoma and MAPK Pathways (4 papers). Clara Martínez-Vila is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (5 papers) and Melanoma and MAPK Pathways (4 papers). Clara Martínez-Vila collaborates with scholars based in Spain, United States and United Kingdom. Clara Martínez-Vila's co-authors include Ana Arance, Cristina Teixidó, Llúcia Alós, Paola Castillo, Yolanda García García, Beatriz García-Paredes, Rolf Richter, Antonio Casado, Marı́a del Monte-Millán and Elena Ioana Braicu and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Clara Martínez-Vila

18 papers receiving 240 citations

Peers

Clara Martínez-Vila
Simona Frezzini Italy
Gopa Iyer United States
Joseph E. Grossman United States
Tongmei Zhang China
Josep Maria de Anta Spain
Florian Roßner Germany
Phuong Vu Norway
Laura N. Mutton United States
Anke Van Lierop Germany
Eleonora Iuliano Italy
Simona Frezzini Italy
Clara Martínez-Vila
Citations per year, relative to Clara Martínez-Vila Clara Martínez-Vila (= 1×) peers Simona Frezzini

Countries citing papers authored by Clara Martínez-Vila

Since Specialization
Citations

This map shows the geographic impact of Clara Martínez-Vila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara Martínez-Vila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara Martínez-Vila more than expected).

Fields of papers citing papers by Clara Martínez-Vila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clara Martínez-Vila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara Martínez-Vila. The network helps show where Clara Martínez-Vila may publish in the future.

Co-authorship network of co-authors of Clara Martínez-Vila

This figure shows the co-authorship network connecting the top 25 collaborators of Clara Martínez-Vila. A scholar is included among the top collaborators of Clara Martínez-Vila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clara Martínez-Vila. Clara Martínez-Vila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Martínez-Vila, Clara, Cristina Teixidó, Roberto Martín, et al.. (2025). Detection of Circulating Tumor DNA in Liquid Biopsy: Current Techniques and Potential Applications in Melanoma. International Journal of Molecular Sciences. 26(2). 861–861. 7 indexed citations
2.
Villacampa, Guillermo, Clara Martínez-Vila, Xavier González, et al.. (2025). 195P Health-related quality of life outcomes in SOLTI VALENTINE: A trial of neoadjuvant HER3-DXd +/- letrozole for high-risk hormone receptor positive/HER2-negative early breast cancer. ESMO Open. 10. 104749–104749. 1 indexed citations
3.
Martínez-Vila, Clara, Europa Azucena González‐Navarro, Cristina Teixidó, et al.. (2024). Lymphocyte T Subsets and Outcome of Immune Checkpoint Inhibitors in Melanoma Patients: An Oncologist’s Perspective on Current Knowledge. International Journal of Molecular Sciences. 25(17). 9506–9506. 3 indexed citations
4.
5.
Serra-Bellver, Patricio, Judith M. Versluis, Cong Zhou, et al.. (2022). Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study. European Journal of Cancer. 176. 121–132. 14 indexed citations
6.
Cortellini, Alessio, Ramón Salazar, Mark Bower, et al.. (2022). Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer. British Journal of Cancer. 127(10). 1787–1792. 5 indexed citations
7.
Serra-Bellver, Patricio, Judith M. Versluis, Cong Zhou, et al.. (2022). Real-World Outcomes with Ipilimumab and Nivolumab in Advanced Melanoma: A Multicentre Retrospective Study. SSRN Electronic Journal. 3 indexed citations
8.
Martínez-Vila, Clara, Gustavo Ares, Guillermo Villacampa, et al.. (2021). Exploratory analysis of clinical benefit of ipilimumab and nivolumab treatment in patients with metastatic melanoma from a single institution. Clinical & Translational Oncology. 24(2). 319–330. 7 indexed citations
9.
Teixidó, Cristina, Paola Castillo, Clara Martínez-Vila, Ana Arance, & Llúcia Alós. (2021). Molecular Markers and Targets in Melanoma. Cells. 10(9). 2320–2320. 124 indexed citations
10.
Martínez-Vila, Clara, Elia Seguí, Joan Padrosa, et al.. (2021). Encephalitis Associated With Immune Checkpoint Inhibitor Treatment in Patients With Melanoma. Journal of Immunotherapy. 44(5). 204–207. 3 indexed citations
11.
Owen, C., Xue Bai, Thuan Chong Quah, et al.. (2020). 1138P Delayed immune-related adverse events (irAEs) on anti-PD1-based therapy. Annals of Oncology. 31. S761–S762. 2 indexed citations
12.
Grabowski, Jacek, Clara Martínez-Vila, Rolf Richter, et al.. (2020). Ki67 expression as a predictor of chemotherapy outcome in low-grade serous ovarian cancer. International Journal of Gynecological Cancer. 30(4). 498–503. 15 indexed citations
13.
García, Yolanda García, et al.. (2020). Anti-angiogenic therapy for ovarian cancer. European Journal of Cancer Supplements. 15. 77–86. 10 indexed citations
14.
Martínez-Vila, Clara, Eva Martínez‐Bauer, Xavier Serra‐Aracil, et al.. (2020). A real world analysis of recurrence risk factors for early colorectal cancer T1 treated with standard endoscopic resection. International Journal of Colorectal Disease. 35(5). 921–927. 5 indexed citations
15.
Grabowski, Jacek, Clara Martínez-Vila, Rolf Richter, et al.. (2019). Association of Ki67 expression levels and therapy outcome in low-grade serous ovarian cancer.. Journal of Clinical Oncology. 37(15_suppl). 5577–5577. 1 indexed citations
16.
Martín, Miguel, Sara López‐Tarruella, Antonio Casado, et al.. (2018). Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling. Breast Cancer Research and Treatment. 171(3). 627–634. 30 indexed citations
17.
Martínez-Vila, Clara, Carles Pericay, Javier Serra, et al.. (2018). A real world analysis of recurrence risk factors for early colorectal cancer T1 treated with standard endoscopic resection.. Journal of Clinical Oncology. 36(4_suppl). 575–575. 1 indexed citations
18.
Darbà, Josep, et al.. (2008). Economic assessment of capecitabine/cisplatin versus 5-FU/cisplatin regimens in adjuvant treatment of advanced gastric cancer in Spain. Journal of Clinical Oncology. 26(15_suppl). 15549–15549.
19.
Borró, J.M., M. Chirivella, Clara Martínez-Vila, et al.. (1992). Successful revascularization of large isolated tracheal segments. European Journal of Cardio-Thoracic Surgery. 6(11). 621–623. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simona Frezzini Breakdown of academic impact, for papers by Gopa Iyer Breakdown of academic impact, for papers by Joseph E. Grossman Breakdown of academic impact, for papers by Tongmei Zhang Breakdown of academic impact, for papers by Josep Maria de Anta Breakdown of academic impact, for papers by Florian Roßner Breakdown of academic impact, for papers by Phuong Vu Breakdown of academic impact, for papers by Laura N. Mutton Breakdown of academic impact, for papers by Anke Van Lierop Breakdown of academic impact, for papers by Eleonora Iuliano
Rankless by CCL
2026